CN102784332A - Medicine for treating angiitis - Google Patents

Medicine for treating angiitis Download PDF

Info

Publication number
CN102784332A
CN102784332A CN2012103181207A CN201210318120A CN102784332A CN 102784332 A CN102784332 A CN 102784332A CN 2012103181207 A CN2012103181207 A CN 2012103181207A CN 201210318120 A CN201210318120 A CN 201210318120A CN 102784332 A CN102784332 A CN 102784332A
Authority
CN
China
Prior art keywords
radix
medicine
rhizoma
parched
brown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012103181207A
Other languages
Chinese (zh)
Other versions
CN102784332B (en
Inventor
张德昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201210318120.7A priority Critical patent/CN102784332B/en
Publication of CN102784332A publication Critical patent/CN102784332A/en
Application granted granted Critical
Publication of CN102784332B publication Critical patent/CN102784332B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a medicine for treating angiitis. The medicine comprises following components: dandelion, bunge corydalis herb, honeysuckle, angelica sinensis, radix scrophulariae, caulis spatholobi, pubescent holly root, codonopsis pilosula, astragalus mongholicus, rhizoma atractylodis macrocephalae, rhizoma dioscoreae, peach kernel, carthamus tinctorius, ligusticum wallichii, earthworm, ground beeltle, centipede, leech, achyranthes bidentata, frankincense, myrrh, pericarpium papaveris, rhizoma corydalis, caramel malt, scorched hawthorn fruit, scorched medicated leaven, radix ophiopogonis, eucommia, semen coicis, poria cocos and liquorice; the medicine is prepared by the following steps: mixing all the medicines according to the parts by weights, adding water to submerge the mixture, decocting and boiling twice, and mixing the two liquid medicines, and then concentrating and parching and processing into medicine powder of 100 meshes, and finally preparing into active pharmaceutical ingredients which can be prepared into any pharmaceutical formulations through a common method, such as troche, pill and capsule. The medicine has functions of eliminating stasis and stopping pain, nourishing liver and kiney, invigorating spleen and replenishing qi, promoting blood circulation of qi, and dredging collaterals; and the total effective rate on treating angiitis reaches 91.5%.

Description

The vasculitic medicine of a kind of treatment
Technical field
The present invention relates to a kind of medicine, the concrete vasculitic medicine of a kind of treatment that relates to the invention still further relates to the method for preparing of this medicine.
Background technology
Vasculitis is for betiding the struvite vascular lesion of chronic progressive external segmental of middle small artery (involving vein and nerve simultaneously); Pathological changes is involved the blood vessel holostrome, causes luminal stenosis, obturation.This disease is mainly invaded limbs; Especially lower limb in, the vein and the skin superficial vein of small artery and companion thereof row; Involved vessels presents the nonsuppurative inflammation of blood vessel wall holostrome, and there have thrombosis, tube chamber to present carrying out property in the tube chamber to be narrow so that entirely shut; Cause limb ischemia and produce pain, the ulcer and the gangrene of healing can take place to be difficult in the severe patient acra.The cause of disease it be unclear that so far.Possibly cause permanent disfunction or limbs to be lost, in addition dead.
At present domestic disease for one type of treatment vasculitis, adopt usually be with injection or oral anti-inflammatory drug thing reaching antiinflammatory, but all be prone to recurrence after treating, and toxic and side effects is big, and complication and sequela are arranged more.
Summary of the invention
The purpose of this invention is to provide a kind of to the treatment vasculitis effective, the medicine that has no side effect.
Medicine of the present invention is to be that crude drug prepares with following parts by weight of traditional Chinese medicines:
Herba Taraxaci 50-80 Herba Corydalis Bungeanaes 50-80 Flos Loniceraes 50-80 Radix Angelicae Sinensis 50-80
Radix Scrophulariae 50-80 Caulis Spatholobis 50-80 Radix Ilicis Pubescentiss 50-80 Radix Codonopsis 10-30
The Radix Astragali 15-30 Rhizoma Atractylodis Macrocephalaes 10-20 Rhizoma Dioscoreaes 10-20 Semen Persicaes 15-20
Flos Carthami 15-30 Rhizoma Chuanxiongs 20-40 Pheretimas 20-30 Eupolyphaga Seu Steleophagas 9-12
Scolopendra 3-5 Hirudos 2-5 Radix Achyranthis Bidentataes 15-20 Olibanum (processed)s 9-15
Myrrha (processed) 9-15 Pericarpium Papaveriss 15-30 Rhizoma Corydalis 15-25 Fructus Hordei Germinatus (parched to brown)s 9-15
Fructus Crataegi (parched to brown) 9-15 Massa Medicata Fermentata (parched to brown) charred Cortex Eucommiae 9-12 9-15 Radix Ophiopogonis 15-20
Semen Coicis 9-15 Poria 9-12 Radix Glycyrrhizaes 15-20.
Further, medicine of the present invention is to be that crude drug prepares with following parts by weight of traditional Chinese medicines:
Herba Taraxaci 60 Herba Corydalis Bungeanaes 65 Flos Loniceraes 60 Radix Angelicae Sinensis 70
Radix Scrophulariae 60 Caulis Spatholobis 65 Radix Ilicis Pubescentiss 65 Radix Codonopsis 15
The Radix Astragali 20 Rhizoma Atractylodis Macrocephalaes 15 Rhizoma Dioscoreaes 15 Semen Persicaes 18
Flos Carthami 16 Rhizoma Chuanxiongs 25 Pheretimas 25 Eupolyphaga Seu Steleophagas 10
Scolopendra 4 Hirudos 4 Radix Achyranthis Bidentataes 18 Olibanum (processed)s 10
Myrrha (processed) 12 Pericarpium Papaveriss 16 Rhizoma Corydalis 20 Fructus Hordei Germinatus (parched to brown)s 12
Fructus Crataegi (parched to brown) 12 Massa Medicata Fermentata (parched to brown) charred Cortex Eucommiae 10 12 Radix Ophiopogonis 18
Semen Coicis 12 Poria 10 Radix Glycyrrhizaes 18.
The method for preparing of medicine of the present invention is following:
(1) the Olibanum stir-fry slightly is yellow to the surface, taking-up cools subsequent use;
(2) it is yellow Myrrha being fried to the surface, and taking-up cools subsequent use;
(3) Cortex Eucommiae is fried to pitchy, take out then,, dry subsequent use with the clear water sprinkle most Mars that goes out;
(4) with said Olibanum (processed), Myrrha (processed) and charred Cortex Eucommiae with add water logging after all the other medicines mix according to said parts by weight and do not have medicine to decoct 1-1.5 hours; Filtration obtains medicinal liquid, adds water logging again and does not have medicine to decoct 40-60 minutes, filters and obtains medicinal liquid; Mix medicinal liquid twice; Concentrate the thick paste that becomes 55 ℃ of relative density 1.25-1.30, the oven dry post-treatment becomes 100 purpose medicated powder, is prepared into medicine activity component.
Can said medicine activity component be processed any pharmaceutical dosage form on the pharmaceutics with conventional method, like tablet, pill, capsule.
The suitable first clearing heat and cooling blood of treatment vasculitis is changed silt, dissipating bind, dampness removing, vein relaxing then, and in the prescription of the present invention, dandelion is clearing heat and detoxicating, dispersing swelling and dissipating binds; Corydlis bungeana is clearing heat and detoxicating, mass dissipating and swelling eliminating; Honeysuckle is clearing heat and detoxicating, dispelling wind and heat from the body; Chinese angelica blood supplementing is invigorated blood circulation, menstruction regulating and pain relieving; The radix scrophulariae clearing heat and cooling blood, replenishing the vital essence and removing heat, purging intense heat and detonicating; Reticulate millettia is enriched blood, and invigorates blood circulation vein relaxing; Ilex pubescens is clearing heat and detoxicating, blood circulation and channel invigorating; Radix Codonopsis invigorating the spleen benefit lung, nourishing blood to promote the production of body fluid; Radix Astragali tonifying Qi and lifting yang, strengthening exterior and reducing sweat, inducing diuresis for removing edema promotes the production of body fluid and nourishes blood, and row stagnates and leads to numbness, pus draining and toxin expelling, expelling pus and promoting granulation; Bighead atractylodes rhizome strengthening the spleen and replenishing qi, eliminating dampness Li Shui; Chinese yam tonifying spleen nourishing the stomach, the beneficial lung that promotes the production of body fluid, the puckery essence of kidney tonifying; The peach kernel promoting blood circulation relaxes bowel; The safflower activating blood to promote menstruation, blood stasis removing analgesic; The Ligusticum wallichii blood-activating and qi-promoting, wind-expelling pain-stopping; Earthworm heat-clearing arresting convulsion, vein relaxing; The ground bettle dissipating blood stasis with potent drugs, reunion of fractured tendons and bones; Centipede breath wind antispastic is removed obstruction in channels to relieve pain dispersing pathogen accumulation; The broken blood of leech stimulates the menstrual flow, by stagnation resolvation disease; The root of bidentate achyranthes stimulates the menstrual flow by the stasis of blood, filling liver kidney, and strengthening the bones and muscles, inducing diuresis for treating strangurtia is ensuringd proper downward flow of the blood; The frankincense analgesic therapy of invigorating blood circulation, detumescence and promoting granulation; The myrrh stasis of blood analgesic therapy of loosing, detumescence and promoting granulation; Pappy shell is astringed the lung, puckery intestines, pain relieving; Corydalis tuber is invigorated blood circulation, promoting the circulation of qi, pain relieving; The melanoidin malt promote qi circulation digestion promoting, spleen benefiting and stimulating the appetite, delaactation dissipate-swelling; Charred FRUCTUS CRATAEGI food digesting stomach fortifying, the promoting the circulation of qi stasis of blood of loosing is changed turbid lipopenicillinase; The stir-baked MASSA FERMENTATA MEDICI-NALIS strengthening the spleen and stomach is aid digestion; The tuber of dwarf lilyturf nourishing Yin and promoting production of body fluid, moistening lung clears away heart-fire; The charred CORTEX EUCOMMIAE filling liver kidney, strengthening the bones and muscles; The coix seed clearing damp and promoting diuresis, invigorating the spleen to arrest diarrhea removes numbness, apocenosis, detoxicating and resolving a mass; The Poria cocos clearing damp and promoting diuresis, invigorating the spleen; Radix Glycyrrhizae is invigorated the spleen and benefited qi, and is clearing heat and detoxicating, expelling phlegm and arresting coughing, relieving spasm to stop pain, coordinating the drug actions of a prescription; All medicines share, loose stasis of blood analgesic therapy, filling liver kidney, invigorate the spleen and benefit qi, blood-activating and qi-promoting, vein relaxing.
The capsule that uses medicine activity component of the present invention to make has clinically carried out safety and observation of curative effect to the treatment vasculitis:
1, patient's situation
Select 89 routine patients, 30-65 years old ages, 38.5 years old mean age, the course of disease 3 months-5 years.Be divided into treatment group and matched group at random, 47 examples are organized in treatment, male 28 examples, women 19 examples, matched group 42 examples, male 25 examples, women 17 examples.
2, diagnostic criteria:
Formulate according to " diagnosis of common disease and efficacy determination (standard) " diagnostic criteria:
(1) is mainly in the lower limb one or both sides, can receives medical histories such as freezing, moist, long-term volume smoking, wound;
(2) toe cold type of pain originally, shank is tingle to swell and ache, and increases the weight of when walking more, alleviates when having a rest, and the limping of having a rest property of travel time is fallen YANG pulse and is alleviated; Shank can have the shallow table property vein of the. fugitive, and the pain that continues is persistence, and acra skin is sent out cold, and then skin is dark red when sagging, cream is purple, xerosis cutis, and hair comes off, and the toenail distortion thickens; Amyotrophy is fallen YANG pulse and is disappeared, and then dry gangrene takes place, and sharp ache is lain awake all night; Sit with one's arms about one's knees, when festering contamination, moist necrosis occurs, acra red and swollen heat pain, whole body heating;
(3) patient is mainly in 20-40 years old male;
(4) ultrasonic doppler, blood figure, nail fold microcirculation, angiography, X line chest are taken the photograph inspections such as sheet, blood fat, blood glucose.
3, get rid of the case standard
(1) age is below 20 years old, over-65s; Gestation or women breast-feeding their children, allergic constitution is to drug allergy or produce than first mate actor;
(2) be associated with serious primary disease person such as liver, kidney, cardiovascular and hemopoietic system;
(3) local secondary infection is swollen and ache and serious symptom dermatosis the infected;
(4) do not meet the standard of including in or, can't judge not by regulation medication person.
4, Therapeutic Method
The capsule that the oral medicine activity component of the present invention of treatment group patient makes, one day twice, each 3, be one month the course of treatment, matched group injection unfractionated heparin sodium injection 6250-12500U adds normal saline 250ml intravenous drip, once a day.
5, efficacy assessment standard
With reference to " diagnosis of common disease and efficacy determination (standard) "
Cure: clinical symptoms disappears basically, and the limbs wound surface heals fully, and limbs peripheral blood circulatory disturbance and impedance type rheography obviously improve, and walking speed 100-120m/min also can continue the above no uncomfortable person of the about 1500m of walking;
Produce effects: clinical symptoms is obviously improved, limbs wound healing or approaching healing, and limbs peripheral blood circulatory disturbance and impedance type rheography all have improvement, and walking speed 100-120m/min also can continue the above person of the about 500m of walking;
Effectively: clinical symptom relief, the limbs wound surface is near healing or dwindling, and limbs peripheral blood circulatory disturbance and impedance type rheography slightly improve, and walking speed 100-120m/min also can continue the above person of the about 300m of walking;
Invalid: treatment back symptom and sign do not have progressive or the state of an illness continues the person of increasing the weight of.
6, therapeutic effect
Treatment is organized among the 47 routine patients, cures 28 examples, cure rate 59.6%, produce effects 8 examples, obvious effective rate 17%; Effective 4 examples, total effective rate 91.5%, invalid 4 examples, inefficiency 8.5%, treatment is organized among the 42 routine patients; Cure 17 examples, cure rate 36.2%, produce effects 6 examples, obvious effective rate 14.3%; Effective 5 examples, total effective rate 66.7%, invalid 14 examples, inefficiency 33.3%.
The specific embodiment
Embodiment 1
Get Herba Taraxaci 0.5kg; Herba Corydalis Bungeanae 0.8 kg; Flos Lonicerae 0.6 kg; Radix Angelicae Sinensis 0.7 kg; Radix Scrophulariae 0.5 kg; Caulis Spatholobi 0.7 kg; Radix Ilicis Pubescentis 0.7 kg; Radix Codonopsis 0.2 kg; The Radix Astragali 0.3 kg; The Rhizoma Atractylodis Macrocephalae 0.1 kg; Rhizoma Dioscoreae 0.15 kg; Semen Persicae 0.2 kg; Flos Carthami 0.2 kg; Rhizoma Chuanxiong 0.3 kg; Pheretima 0.3 kg; Eupolyphaga Seu Steleophaga 0.1 kg; Scolopendra 0.03 kg; Hirudo 0.05 kg; Radix Achyranthis Bidentatae 0.15kg; Olibanum (processed) 0.1kg; Myrrha (processed) 0.15 kg; Pericarpium Papaveris 0.2 kg; Rhizoma Corydalis 0.25 kg; Fructus Hordei Germinatus (parched to brown) 0.1 kg; Fructus Crataegi (parched to brown) 0.1 kg; Massa Medicata Fermentata (parched to brown) 0.1 kg; Radix Ophiopogonis 0.2 kg; Charred Cortex Eucommiae 0.09 kg; Semen Coicis 0.1 kg; Poria 0.12 kg; Radix Glycyrrhizae 0.2 kg;
Said medicine is added 25 kg decoctings boiled 1-1.5 hours, filter and obtain medicinal liquid, add 20 kg decoctings again and boiled 40-60 minutes; Filtration obtains medicinal liquid; Mix medicinal liquid twice, concentrate the thick paste that becomes 55 ℃ of relative density 1.25-1.30, the oven dry post-treatment becomes 100 purpose medicated powder; Be prepared into medicine activity component, adding starch incapsulates shell and processes capsule.
Embodiment 2
Herba Taraxaci 0.8 kg; Herba Corydalis Bungeanae 1.2 kg; Flos Lonicerae 1.1 kg; Radix Angelicae Sinensis 0.8 kg; Radix Scrophulariae 1.2 kg; Caulis Spatholobi 1.1 kg; Radix Ilicis Pubescentis 0.8 kg; Radix Codonopsis 0.45 kg; The Radix Astragali 0.32 kg; The Rhizoma Atractylodis Macrocephalae 0.2 kg; Rhizoma Dioscoreae 0.3 kg; Semen Persicae 0.25 kg; Flos Carthami 0.45 kg; Rhizoma Chuanxiong 0.35 kg; Pheretima 0.38 kg; Eupolyphaga Seu Steleophaga 0.15 kg; Scolopendra 0.05 kg; Hirudo 0.03 kg; Radix Achyranthis Bidentatae 0.3 kg; Olibanum (processed) 0.15 kg; Myrrha (processed) 0.2 kg; Pericarpium Papaveris 0.35 kg; Rhizoma Corydalis 0.08 kg; Fructus Hordei Germinatus (parched to brown) 0.15 kg; Fructus Crataegi (parched to brown) 0.15 kg; Massa Medicata Fermentata (parched to brown) 0.15 kg; Radix Ophiopogonis 0.3 kg; Charred Cortex Eucommiae 0.16 kg; Semen Coicis 0.15 kg; Poria 0.2 kg; Radix Glycyrrhizae 0.3 kg;
Said medicine is added 37 kg decoctings boiled 1-1.5 hours, filter and obtain medicinal liquid, add 30 kg decoctings again and boiled 40-60 minutes; Filtration obtains medicinal liquid, mixes medicinal liquid twice, concentrates the thick paste that becomes 55 ℃ of relative density 1.25-1.30; The oven dry post-treatment becomes 100 purpose medicated powder; Be prepared into medicine activity component, add starch, dextrin, Icing Sugar and calcium sulfate two water things, compacting in flakes.
Embodiment 3
Herba Taraxaci 1 kg; Herba Corydalis Bungeanae 1.4 kg; Flos Lonicerae 1.6 kg; Radix Angelicae Sinensis 1 kg; Radix Scrophulariae 1.4 kg; Caulis Spatholobi 1.6 kg; Radix Ilicis Pubescentis 1.5 kg; Radix Codonopsis 0.2 kg; The Radix Astragali 0.5 kg; The Rhizoma Atractylodis Macrocephalae 0.4 kg; Rhizoma Dioscoreae 0.3 kg; Semen Persicae 0.35 kg; Flos Carthami 0.3 kg; Rhizoma Chuanxiong 0.8 kg; Pheretima 0.4 kg; Eupolyphaga Seu Steleophaga 0.2 kg; Scolopendra 0.1 kg; Hirudo 0.06 kg; Radix Achyranthis Bidentatae 0.3 kg; Olibanum (processed) 0.2 kg; Myrrha (processed) 0.3 kg; Pericarpium Papaveris 0.5 kg; Rhizoma Corydalis 0.5 kg; Fructus Hordei Germinatus (parched to brown) 0.2 kg; Fructus Crataegi (parched to brown) 0.2 kg; Massa Medicata Fermentata (parched to brown) 0.2 kg; Radix Ophiopogonis 0.2 kg; Charred Cortex Eucommiae 0.18 kg; Semen Coicis 0.3 kg; Poria 0.2 kg; Radix Glycyrrhizae 0.4 kg;
Said medicine is added 50 kg decoctings boiled 1-1.5 hours, filter and obtain medicinal liquid, add 45 kg decoctings again and boiled 40-60 minutes; Filtration obtains medicinal liquid; Mix medicinal liquid twice, concentrate the thick paste that becomes 55 ℃ of relative density 1.25-1.30, the oven dry post-treatment becomes 100 purpose medicated powder; Be prepared into medicine activity component, the Mel that adding can make active component be mixed into ball is processed pill.

Claims (3)

1. treat vasculitic medicine for one kind, it is characterized in that it is that crude drug prepares by the Chinese medicine of following portions by weight:
Herba Taraxaci 50-80 Herba Corydalis Bungeanaes 50-80 Flos Loniceraes 50-80 Radix Angelicae Sinensis 50-80
Radix Scrophulariae 50-80 Caulis Spatholobis 50-80 Radix Ilicis Pubescentiss 50-80 Radix Codonopsis 10-30
The Radix Astragali 15-30 Rhizoma Atractylodis Macrocephalaes 10-20 Rhizoma Dioscoreaes 10-20 Semen Persicaes 15-20
Flos Carthami 15-30 Rhizoma Chuanxiongs 20-40 Pheretimas 20-30 Eupolyphaga Seu Steleophagas 9-12
Scolopendra 3-5 Hirudos 2-5 Radix Achyranthis Bidentataes 15-20 Olibanum (processed)s 9-15
Myrrha (processed) 9-15 Pericarpium Papaveriss 15-30 Rhizoma Corydalis 15-25 Fructus Hordei Germinatus (parched to brown)s 9-15
Fructus Crataegi (parched to brown) 9-15 Massa Medicata Fermentata (parched to brown) charred Cortex Eucommiae 9-12 9-15 Radix Ophiopogonis 15-20
Semen Coicis 9-15 Poria 9-12 Radix Glycyrrhizaes 15-20.
2. the vasculitic medicine of treatment according to claim 1 is characterized in that by following parts by weight of traditional Chinese medicines being that crude drug prepares:
Herba Taraxaci 60 Herba Corydalis Bungeanaes 65 Flos Loniceraes 60 Radix Angelicae Sinensis 70
Radix Scrophulariae 60 Caulis Spatholobis 65 Radix Ilicis Pubescentiss 65 Radix Codonopsis 15
The Radix Astragali 20 Rhizoma Atractylodis Macrocephalaes 15 Rhizoma Dioscoreaes 15 Semen Persicaes 18
Flos Carthami 16 Rhizoma Chuanxiongs 25 Pheretimas 25 Eupolyphaga Seu Steleophagas 10
Scolopendra 4 Hirudos 4 Radix Achyranthis Bidentataes 18 Olibanum (processed)s 10
Myrrha (processed) 12 Pericarpium Papaveriss 16 Rhizoma Corydalis 20 Fructus Hordei Germinatus (parched to brown)s 12
Fructus Crataegi (parched to brown) 12 Massa Medicata Fermentata (parched to brown) charred Cortex Eucommiae 10 12 Radix Ophiopogonis 18
Semen Coicis 12 Poria 10 Radix Glycyrrhizaes 18.
3. claim 1 or the vasculitic medicine of 2 said treatments, its preparation method is following:
(1) the Olibanum stir-fry slightly is yellow to the surface, taking-up cools subsequent use;
(2) it is yellow Myrrha being fried to the surface, and taking-up cools subsequent use;
(3) Cortex Eucommiae is fried to pitchy, take out then,, dry subsequent use with the clear water sprinkle most Mars that goes out;
(4) with said Olibanum (processed), Myrrha (processed) and charred Cortex Eucommiae with add water logging after all the other medicines mix according to said parts by weight and do not have medicine to decoct 1-1.5 hours; Filtration obtains medicinal liquid; Add water logging again and do not have medicine to decoct 40-60 minutes, mix medicinal liquid twice, concentrate the thick paste that becomes 55 ℃ of relative density 1.25-1.30; The oven dry post-treatment becomes 100 purpose medicated powder, is prepared into medicine activity component.
CN201210318120.7A 2012-09-01 2012-09-01 Medicine for treating angiitis Expired - Fee Related CN102784332B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210318120.7A CN102784332B (en) 2012-09-01 2012-09-01 Medicine for treating angiitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210318120.7A CN102784332B (en) 2012-09-01 2012-09-01 Medicine for treating angiitis

Publications (2)

Publication Number Publication Date
CN102784332A true CN102784332A (en) 2012-11-21
CN102784332B CN102784332B (en) 2014-03-12

Family

ID=47150049

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210318120.7A Expired - Fee Related CN102784332B (en) 2012-09-01 2012-09-01 Medicine for treating angiitis

Country Status (1)

Country Link
CN (1) CN102784332B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103211911A (en) * 2013-04-28 2013-07-24 长治市郊区黄碾镇中心卫生院 Medicine for treating thromboangiitis obliterans
CN103285360A (en) * 2013-06-09 2013-09-11 王京涛 Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof
CN104042982A (en) * 2014-06-26 2014-09-17 李涛 Traditional Chinese medicine composition for treating angitis and preparation method thereof
CN106109699A (en) * 2016-08-29 2016-11-16 辽宁恩群蟾蜍科技有限公司 A kind of Chinese medicine composition treating artery and vein blood vessel obliterans

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679843A (en) * 2005-01-27 2005-10-12 朱腾月 Oral medicine for treating thromboangitis obliterans
CN101002917A (en) * 2006-11-04 2007-07-25 于曼秋 Chinese medicine for treating thromboangitis obliterans

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1679843A (en) * 2005-01-27 2005-10-12 朱腾月 Oral medicine for treating thromboangitis obliterans
CN101002917A (en) * 2006-11-04 2007-07-25 于曼秋 Chinese medicine for treating thromboangitis obliterans

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
王慧珠: "活络效灵丹加味治疗血栓闭塞性脉管炎", 《武汉职工医学院学报》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103211911A (en) * 2013-04-28 2013-07-24 长治市郊区黄碾镇中心卫生院 Medicine for treating thromboangiitis obliterans
CN103285360A (en) * 2013-06-09 2013-09-11 王京涛 Traditional Chinese medicinal preparation for treating thromboangiitis obliterans, and preparation method thereof
CN104042982A (en) * 2014-06-26 2014-09-17 李涛 Traditional Chinese medicine composition for treating angitis and preparation method thereof
CN106109699A (en) * 2016-08-29 2016-11-16 辽宁恩群蟾蜍科技有限公司 A kind of Chinese medicine composition treating artery and vein blood vessel obliterans

Also Published As

Publication number Publication date
CN102784332B (en) 2014-03-12

Similar Documents

Publication Publication Date Title
CN103920117A (en) Chinese medicinal composition for treating gout and preparation method thereof
CN103071128A (en) Externally-applied plaster for curing dysmenorrhea
CN104225441A (en) Traditional Chinese medicine composition for treating stomach trouble and preparation method of granules and capsules of traditional Chinese medicine composition
CN102784332B (en) Medicine for treating angiitis
CN105031213A (en) Traditional Chine medicine foot bathing powder for treating arthritis and preparation method thereof
CN104771740A (en) Traditional Chinese medicine composition for treating rheumatic arthritis
CN103272143A (en) Traditional Chinese medicine composition for treating acne
CN105012735B (en) One kind fills blood anticancer traditional Chinese medicinal composition
CN101690797B (en) Traditional Chinese medicine for treating rheumatism and rheumatoid diseases
CN101204494B (en) Medicine for chronic enteritis
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN103550548B (en) A kind of Chinese medicine composition for the treatment of constipation
CN103239656A (en) Traditional Chinese medicine for treating psoriasis
CN102327524A (en) Traditional Chinese medicine composition for curing erysipelas
CN108888735B (en) Traditional Chinese medicine composition for treating chronic constipation
CN102512543B (en) Chinese medicinal composition for treating rheumatoid arthritis
CN105727001A (en) Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases
CN105477330A (en) Traditional Chinese medicine composition for treating arrhythmia
CN105031505A (en) Medicine for treating benign prostatic hyperplasia hypertrophy and preparation method thereof
CN103585589A (en) Medicine for treating chronic rheumatoid arthritis
CN103028063B (en) Traditional Chinese medicine composition for treating nephropathy
CN106344793A (en) Traditional Chinese medicine foot bath powder for treating arthritis and preparation method thereof
CN102488818B (en) Pharmaceutical composition for treating rheumatism and rheumatoid arthritis
CN101985027A (en) Chinese herbal medicine for treating liver cirrhosis
CN101983712A (en) Novel medicament for treating coronary heart disease

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20140312

Termination date: 20140901

EXPY Termination of patent right or utility model